Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;23(2):1086-1094.
doi: 10.1111/jcmm.14009. Epub 2018 Nov 19.

Unveiling Ga(III) phthalocyanine-a different photosensitizer in neuroblastoma cellular model

Carolina Constantin  1   2 , Andreea-Roxana Lupu  1 , Tudor Emanuel Fertig  3 , Mihaela Gherghiceanu  3 , Sevinci Pop  4 , Rodica-Mariana Ion  5 , Monica Neagu  1   2   6
Affiliations

Unveiling Ga(III) phthalocyanine-a different photosensitizer in neuroblastoma cellular model

Carolina Constantin et al. J Cell Mol Med. 2019 Feb.

Abstract

Phthalocyanines (Pc) and their metallated derivatives are strongly considered for photodynamic therapy (PDT) possessing unique properties as possible new photosensitizers (PS). We have used toxicological assessments, real-time monitoring of cellular impedance, and imagistic measurements for assessing the in vitro dark toxicity and PDT efficacy of Ga(III)-Pc in SHSy5Y neuroblastoma cells. We have established the non-toxic concentration range of Ga(III)-Pc, a compound which shows a high intracellular accumulation, with perinuclear distribution in confocal microscopy. By choosing Ga(III)Pc non-toxic dose, we performed in vitro experimental PDT hampering cellular proliferation. Our proposed Ga(III)-Pc could complete a future PS panel for neuroblastoma alternate therapy.

Keywords: gallium(III); neuroblastoma; photodynamic therapy; photosensitizer; proliferation; toxicity; tumour; viability.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Cellular viability assessed as lactate dehydrogenase (LDH) index for SHSy5Y cells incubated with Ga(III)Pc for different time‐points. (B) Cellular proliferation index for SHSy5Y cells incubated with Ga(III)Pc at different time‐points—assessed by MTS reduction in metabolically active cells
Figure 2
Figure 2
Cell index for SHSy5Y cells treated with Ga(III)Pc; 2000 cells/well; red = control (unloaded cells), green = DMSO, dark blue = 2 μg/mL GaPcCl; purple = 10 μg/mL Ga(III)Pc; light blue = 50 μg/mL Ga(III)Pc; black arrow detail—point when compound Ga(III)Pc is added to cells
Figure 3
Figure 3
Cellular index (CI) for cellular impedance measurements—automated CI for 2, 24, 48, 72, and 120 h of SHSy5Y treated with various doses of Ga(III)Pc
Figure 4
Figure 4
Confocal microscopy of SHSy5Y cells treated with Ga(III)Pc, showing the distribution of the compound. (A) Control—SHSy5Y cells without Ga(III)Pc, stained with phalloidin for F‐actin (green) and DAPI (blue). (B) SHSy5Y cells loaded with Ga(III)Pc (red) and stained with phalloidin (green) and DAPI (blue) show similar morphology to control cells. (C) Digital zoom of SHSy5Y cells loaded with Ga(III)Pc (red), showing a cytosolic, predominantely perinuclear distribution of the compound
Figure 5
Figure 5
(A) Lactate dehydrogenase (LDH) release after experimental photodynamic therapy (PDT) of SHSy5Y loaded with 10 μg/mL Ga(III)Pc. (B) Proliferation index after experimental PDT of SHSy5Y loaded with 10 μg/mL Ga(III)Pc
Figure 6
Figure 6
Impedance measurements results—cell index at first 24 h post‐PDT; (A) detail on first 18 h of monitoring; (B) detail on first 2 h of monitoring
Figure 7
Figure 7
Cellular index of irradiated SHSy5Y cells loaded with Ga(III)Pc 10 μg/mL after different time periods cultivation post‐irradiation
See this image and copyright information in PMC

References

    1. Master AM, Livingston M, Oleinick NL, Sen Gupta A. Optimization of a nanomedicine‐based silicon phthalocyanine 4 photodynamic therapy (Pc 4‐PDT) strategy for targeted treatment of EGFR‐overexpressing cancers. Mol Pharm. 2012;9(8):2331‐2338. - PMC - PubMed
    1. Dongen GAMSV, Visser GWM, Vrouenraets MB. Photosensitizer‐antibody conjugates for detection and therapy of cancer. Adv Drug Deliv Rev. 2004;56:31‐52. - PubMed
    1. Moan J, Peng Q. An outline of the hundred‐year history of PDT. Anticancer Res. 2003;23(5A):3591‐3600. - PubMed
    1. Maeding N, Verwanger T, Krammer B. Boosting tumor‐specific immunity using PDT. Cancers (Basel). 2016;8(10):pii: E91. - PMC - PubMed
    1. Maduray K, Odhav B. The in vitro photodynamic effect of laser activated gallium, indium and iron phthalocyanine chlorides on human lung adenocarcinoma cells. J Photochem Photobiol, B. 2013;128:58‐63. - PubMed

Publication types

MeSH terms